AAAAAA

   
Results: 1-4 |
Results: 4
Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells
Authors: Jarman, ER Perschke, K Montermann, E Herz, U Renz, H Knop, J Reske-Kunz, AB
Citation: Er. Jarman et al., Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells, J ALLERG CL, 105(5), 2000, pp. 967-974
Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis
Authors: Klimek, L Dormann, D Jarman, ER Cromwell, O Riechelmann, H Reske-Kunz, AB
Citation: L. Klimek et al., Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis, CLIN EXP AL, 29(10), 1999, pp. 1326-1335
Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide
Authors: Jarman, ER Kuba, A Montermann, E Bartlett, RR Reske-Kunz, AB
Citation: Er. Jarman et al., Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide, CLIN EXP IM, 115(2), 1999, pp. 221-228
Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids)
Authors: Dormann, D Ebner, C Jarman, ER Montermann, E Kraft, D Reske-Kunz, AB
Citation: D. Dormann et al., Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids), CLIN EXP AL, 28(11), 1998, pp. 1374-1383
Risultati: 1-4 |